These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 33004529)

  • 1. Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis.
    José RJ; Williams A; Manuel A; Brown JS; Chambers RC
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
    Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
    Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
    Boccia M; Aronne L; Celia B; Mazzeo G; Ceparano M; D'Agnano V; Parrella R; Valente T; Bianco A; Perrotta F
    Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coagulopathy and COVID-19. Recommendations for a changing reality].
    Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
    Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
    Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
    Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2020 - Year of COVID-19.
    Lillicrap D; Morrissey JH
    J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboinflammatory response in SARS-CoV-2 sepsis.
    Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD
    Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 11. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
    Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J
    J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic events and Covid-19.
    Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and SIC (!).
    Nevzorov I; Tulamo R; Albäck A; Lassila R
    J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
    [No Abstract]   [Full Text] [Related]  

  • 15. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
    Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
    J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.
    Xiong M; Liang X; Wei YD
    Br J Haematol; 2020 Jun; 189(6):1050-1052. PubMed ID: 32304581
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study.
    Tanaka S; De Tymowski C; Assadi M; Zappella N; Jean-Baptiste S; Robert T; Peoc'h K; Lortat-Jacob B; Fontaine L; Bouzid D; Tran-Dinh A; Tashk P; Meilhac O; Montravers P
    PLoS One; 2020; 15(9):e0239573. PubMed ID: 32970772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
    Mazzeffi M; Chow JH; Amoroso A; Tanaka K
    Anesth Analg; 2020 Sep; 131(3):690-693. PubMed ID: 32541255
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
    Bhaskar S; Sinha A; Banach M; Mittoo S; Weissert R; Kass JS; Rajagopal S; Pai AR; Kutty S
    Front Immunol; 2020; 11():1648. PubMed ID: 32754159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers associated with COVID-19 disease progression.
    Ponti G; Maccaferri M; Ruini C; Tomasi A; Ozben T
    Crit Rev Clin Lab Sci; 2020 Sep; 57(6):389-399. PubMed ID: 32503382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.